Publication | Closed Access
Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
55
Citations
0
References
1988
Year
UrologyRenal FunctionKidney TransplantKidney FailureChronic Kidney DiseaseDose-related EffectsMulticenter TrialNephrologyRenal PathophysiologyMedicineEnd-stage Renal DiseaseKidney Research
No additional data available for this publication yet. Check back later!